Triple-negative breast cancers (TNBC) are a diverse subgroup of breast cancer defined by the absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) expression. This evidence concerns the gene PGR and breast cancer.